Back to School: How biopharma can reboot drug development. Access exclusive analysis here
A jury ruled that Mircera methoxy polyethylene glycol-epoetin beta from Roche (SWX:ROG) infringes
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury